Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients

ConditionsTracheal Intubation Morbidity Laryngoscopy Hemodynamic Response

Trial statusNot yet recruiting

Trial phasePhase 2, Phase 3

Trial typeInterventional

Biological sexAll

Age40-60

SponsorTanta University

About this trial

The aim of this study is to compare the efficacy of oral melatonin versus nebulized dexmedetomidine in attenuating the hemodynamic response to direct laryngoscopy and endotracheal intubation in controlled hypertensive patients prepared for general anesthesia

Eligibility criteria

Qualifiers

Age (40-60) years of both genders.

Controlled hypertensive patients.

Categorized as ASA physical status II.

Planning to do an elective surgery under General Anesthesia.

Disqualifiers

Patient refusal to participate in the study.

Patient with expected difficult intubation.

Body Mass Index (BMI) > 30 kg/m2.

History of allergy to the drugs of the study.

Trial design

Treatments tested in this trial

Dexmedetomidine
Melatonin

Treatment groups

70 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Tanta University

Lead sponsor

Source ClinicalTrials.gov